Go Pro
→ Major Buy Alert Issued for September 30th (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
$10.79
-0.2%		$12.68
$10.51
▼
$28.48
$1.83M-1.198,091 shs11,789 shs
CNCR
Range Cancer Therapeutics ETF
$9.02
$30.00
$8.67
▼
$10.30
$7.04M0.952,466 shsN/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
$63.19
-0.3%		$61.59
$50.34
▼
$64.69
$9.48M0.39707 shs16 shs
MEDX
Horizon Kinetics Medical ETF
$37.08
-0.3%		$36.14
$28.87
▼
$37.90
$18.17M0.462,059 shs1,920 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
-0.19%+0.65%-19.96%-37.88%-61.10%
CNCR
Range Cancer Therapeutics ETF
0.00%0.00%0.00%0.00%-3.22%
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
-0.27%-1.34%+5.00%+10.99%+22.48%
MEDX
Horizon Kinetics Medical ETF
-0.27%+0.52%+7.07%+7.54%+27.58%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
$10.79
-0.2%		$12.68
$10.51
▼
$28.48
$1.83M-1.198,091 shs11,789 shs
CNCR
Range Cancer Therapeutics ETF
$9.02
$30.00
$8.67
▼
$10.30
$7.04M0.952,466 shsN/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
$63.19
-0.3%		$61.59
$50.34
▼
$64.69
$9.48M0.39707 shs16 shs
MEDX
Horizon Kinetics Medical ETF
$37.08
-0.3%		$36.14
$28.87
▼
$37.90
$18.17M0.462,059 shs1,920 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
-0.19%+0.65%-19.96%-37.88%-61.10%
CNCR
Range Cancer Therapeutics ETF
0.00%0.00%0.00%0.00%-3.22%
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
-0.27%-1.34%+5.00%+10.99%+22.48%
MEDX
Horizon Kinetics Medical ETF
-0.27%+0.52%+7.07%+7.54%+27.58%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
0.00
N/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
0.00
N/AN/AN/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
2.79
Moderate Buy$63.19N/A
MEDX
Horizon Kinetics Medical ETF
2.68
Moderate Buy$37.08N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
N/AN/AN/AN/AN/AN/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
N/AN/A22.43N/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/A19.02N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
$0.787.23%N/AN/AN/A
CNCR
Range Cancer Therapeutics ETF
$0.293.22%N/AN/AN/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
$0.320.51%N/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
$0.501.35%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A
CNCR
Range Cancer Therapeutics ETF
N/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
N/A
MEDX
Horizon Kinetics Medical ETF
62.18%

Insider Ownership

CompanyInsider Ownership
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A
CNCR
Range Cancer Therapeutics ETF
N/A
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
N/A
MEDX
Horizon Kinetics Medical ETF
4.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
ProShares UltraShort Nasdaq Biotechnology stock logo
BIS
ProShares UltraShort Nasdaq Biotechnology
N/A170,000N/AOptionable
CNCR
Range Cancer Therapeutics ETF
N/A780,814N/ANot Optionable
JPMorgan Healthcare Leaders ETF stock logo
JDOC
JPMorgan Healthcare Leaders ETF
N/A150,000N/AN/A
MEDX
Horizon Kinetics Medical ETF
N/A490,000N/ANot Optionable

Recent News About These Companies

Medical ETF (MEDX) Touches New 52-Week High
February 24, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2874077/medical-etf-medx-touches-new-52-week-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2874077
Horizon Kinetics Holding Corporation Reports First Quarter Results
May 14, 2025  |  accessnewswire.comA
Horizon Kinetics Holding Corporation Reports Fourth Quarter and Annual Results
March 26, 2025  |  accessnewswire.comA
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 1, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2266174/etfs-to-buy-as-eli-lilly-beats-q1-earnings-lifts-outlook?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2266174
Horizon Kinetics ISE Wealth (RCH)
May 13, 2023  |  uk.investing.comhttps://uk.investing.com/indices/horizon-kinetics-ise-wealth
HORIZON Fushi ChinaA 50 ETF (512150)
May 11, 2023  |  investing.comhttps://www.investing.com/etfs/horizon-fushi-chinaa-50
Horizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)
April 19, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/horizon-kinetics-launches-horizon-kinetics-213500961.html?.tsrc=rss

Media Sentiment Over Time

Top Headlines

View All Headlines
Rows of illuminated server racks with blue lighting line a data center corridor.
AI Data Centers Are Splitting Winners From Pretenders in Infrastructure Stocks
By Jeffrey Neal Johnson | August 10, 2026
An upward-trending arrow drawn in beach sand, symbolizing rising stock prices, with beachgoers in the background.
3 Stocks Taking Very Different Routes Through the Summer Rally
By Nathan Reiff | August 5, 2026
Nebius logo illuminated in green and blue neon light within a server data center aisle.
Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
By Thomas Hughes | August 12, 2026
Curaleaf logo displayed with cannabis leaves and a bud on a reflective surface against a dark green background.
Joint Operations: Curaleaf Makes a Play for Aurora Cannabis
By Jeffrey Neal Johnson | August 14, 2026
Coherent logo displayed over an illuminated fiber optic cable, semiconductor wafer, and network transceiver module.
Coherent Stock Is Cooling Off Just as Its AI Thermal Opportunity Heats Up
By Jeffrey Neal Johnson | August 21, 2026
ProShares UltraShort Nasdaq Biotechnology stock logo

ProShares UltraShort Nasdaq Biotechnology NASDAQ:BIS

$10.79 -0.02 (-0.19%)
As of 09/3/2026 03:54 PM Eastern

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in equity securities and derivatives that have similar daily performance characteristics as twice (200%) the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

Range Cancer Therapeutics ETF NASDAQ:CNCR

The Loncar Cancer Immunotherapy ETF (CNCR) is an exchange-traded fund that is based on the Loncar Cancer Immunotherapy index. The fund tracks an equal-weighted index of companies currently producing or in clinical trials for cancer immunotherapy drugs. CNCR was launched on Oct 13, 2015 and is managed by Loncar.

JPMorgan Healthcare Leaders ETF stock logo

JPMorgan Healthcare Leaders ETF NASDAQ:JDOC

$63.19 -0.17 (-0.27%)
As of 09/3/2026 10:20 AM Eastern
This is a fair market value price provided by Massive. Learn more.

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.

Horizon Kinetics Medical ETF NASDAQ:MEDX

$37.08 -0.10 (-0.27%)
As of 09/3/2026 03:50 PM Eastern

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas